In a bold move, the Trump administration has petitioned the U.S. Supreme Court to intervene and allow the deployment of troops in Illinois, intensifying federal efforts to bolster security in the Chicago area. What does this mean for the city?
The Trump administration is appealing to the Supreme Court to deploy National Guard troops in Illinois after lower court rulings blocked the move. This decision comes amid concerns for federal agent safety in Chicago.
Boeing plans to ramp up 737 production to 42 planes per month, aiming for financial recovery after years of debt. Enhanced FAA oversight ensures safety amid supply chain challenges.
Boeing has received FAA approval to ramp up 737 Max production to 42 jets monthly, marking a significant turnaround for the company after years of challenges and scrutiny. This move comes as Boeing aims to stabilize and boost its output amidst past safety concerns.
A federal judge has issued a temporary restraining order against President Trump's plan to deploy the National Guard in Portland, ruling that the situation does not warrant federal intervention. Oregon officials celebrate the decision, asserting local law enforcement can handle the protests.
The Minnesota Public Utilities Commission has approved BlackRock's takeover of Minnesota Power, ignoring warnings that it could lead to higher bills and reduced oversight. Critics fear this decision prioritizes profits over public interest.
The FDA's approval of a new generic version of mifepristone has sparked backlash from anti-abortion groups and GOP politicians. Critics say it's a political move during a heated debate over abortion rights.
In a surprising twist, Danica Patrick criticizes Bad Bunny's upcoming Super Bowl halftime performance, claiming no English songs belong at the event. Patrick's remarks spark debate on cultural representation and music at major sports events.
A new NPR/PBS News/Marist poll shows Republicans could face more blame than Democrats if the government shuts down. Many Americans believe both parties share the responsibility, highlighting a deep divide in public opinion.
The Trump administration's recent approval of leucovorin as an autism treatment has sparked outrage among experts, with many calling for more research and caution in prescribing this unproven drug.